Updates

Author Details

Joe Pierce

October 26, 2020October 22, 2020
Embracing Happiness When Caring for a Loved One With Alzheimer’s

“A cheerful heart is good medicine.” — Proverbs 17:22 You may recognize that verse, which is often paraphrased as “Laughter is good medicine.” And ... Read more
October 26, 2020October 26, 2020
Simple Language Test May Predict Alzheimer’s Onset Years Before Symptoms Start

A simple language test, when combined with an artificial intelligence model, can predict which people will develop Alzheimer’s disease later in life, a study ... Read more
October 21, 2020October 21, 2020
RetiSpec and Gentex Developing Technology to Detect Early Alzheimer’s

RetiSpec and Gentex are partnering to develop a technology to detect Alzheimer’s disease — potentially years before symptom onset — using a non-invasive and cost-effective ... Read more
October 19, 2020October 15, 2020
Caregivers Should Connect to Breast Cancer Awareness

October is Breast Cancer Awareness Month, and of course, its purpose is to create buzz and mindfulness about the disease. In the United States, ... Read more
October 19, 2020October 19, 2020
First Patient Dosed in Phase 2 Trial of Bryostatin-1 in Long-term Use

A first patient has been dosed in a Phase 2 trial investigating the safety and long-term efficacy of bryostatin-1 in treating moderate and moderately ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Author Details

Joe Pierce

Thanks! Please check your email for a confirmation email.

November 8, 2017November 8, 2017

Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment

News

Anavex Life Sciences says its Alzheimer’s drug candidate Anavex 2-73 may have a role in treating the disease. Data from a long-term extension trial, although small, indicated that the therapy improved cognitive and functional measures in patients. According to data ... Read more

Embracing Happiness When Caring for a Loved One With Alzheimer’s

Simple Language Test May Predict Alzheimer’s Onset Years Before Symptoms Start

RetiSpec and Gentex Developing Technology to Detect Early Alzheimer’s

Caregivers Should Connect to Breast Cancer Awareness

First Patient Dosed in Phase 2 Trial of Bryostatin-1 in Long-term Use

GemVax Seeks Expanded Access for Mild Alzheimer’s for Planned GV1001 US Trial

The Reality of Death and Caregiving

Dosing Starts in Phase 2/3 Trial of Athira’s ATH-1017 for Alzheimer’s

Semorinemab Fails to Show Efficacy in Early Alzheimer’s Phase 2 Trial

Creating a Last Will and Testament to Care for a Loved One

$1.76M Grant to Support Trial of Jotrol, Form of Resveratrol, in Early Alzheimer’s

Subscribe to our mailing list

Mundane Errands Become Worthwhile Adventures With Alzheimer’s Disease

CDC Taps Alzheimer’s Association to Lead National Effort to Slash Dementia Risk

Sumifilam Lowers Levels of Multiple Biomarkers of Disease Activity, Trial Shows

Preventing Bias Against People With Alzheimer’s Disease

Specific Tau Protein Shows Potential as Blood Biomarker in Early Studies

Theme for World Alzheimer’s Month Is ‘Let’s Talk About Dementia’

The Dirty Secret Behind Caregiving

Phase 3 Trial of AXS-05 to Treat Agitation in Alzheimer’s Likely by Year’s End

First Patients Dosed in Annovis Bio’s ANVS401 Trial, Delayed Due to COVID-19

Part the Cloud Awards $24M to Researchers Studying Potential Alzheimer’s Treatments

Alzheimer’s Care During a Catastrophic Event

Technique That Opens Blood-Brain Barrier May Help Target Treatment, Study Says

Patients in Australian Trials of Anavex 2-73 May Continue Using Therapy, Agency Says

Caregivers Face Increased Health Risks Compared With Noncaregivers

GAIN Trial Reaches Milestone With 500 Patients Enrolled

AFA Awards $518K for Study of Neuroimmune Interactions in AD Onset, Progression

How to Support a Friend With Alzheimer’s and Their Family

AC Immune Moves Closer to Clinical Studies of Anti-TDP-43 Antibody

XPro1595 Lowers Neuroinflammation in Mild to Moderate Alzheimer’s, Interim Results Show

Young People May Exhibit Risks Associated With Alzheimer’s Disease, Research Finds

Aducanumab Wins FDA Priority Review, Moves Closer to US Approval

Rare Disease Communities Invited to Submit Works to 2020 Rare Artist Contest

Why an Aging Population Might Not Exercise

Trial of Potential Alzheimer’s Vaccine Advances to Medium Dose Group

People With Alzheimer’s Disease Often Resist Loss of Control

Flu, Pneumonia Vaccinations Linked to Reduced Risk of Alzheimer’s, Researchers Say

FDA to Consider Nuplazid to Treat Dementia-related Psychosis

Care Facilities Lockdown Is Hard on Parents with Dementia

Global Phase 3 Trial Will Test BAN2401 in Early-stage Asymptomatic Alzheimer’s

Alzheimer’s Foundation Expands Toll-free Helpline to Support Patients, Caregivers

Will Alzheimer’s Disease Affect Voter Turnout by Seniors?